Dawson Gershuny

Associate | He/Him/His

Overview

Dawson is an associate at Crowell & Moring’s Chicago office, focusing on patent litigation. He works with clients globally, gaining insight into their distinct business needs and concerns.

Dawson has supported partners and counsels in complex patent litigation, helping to develop strategies to protect and enforce clients' patent rights across various industries. He has also managed patent applications, ensuring clients' innovations are protected through drafting responses to office actions before the U.S. Patent and Trademark Office. Dawson works with clients both in the U.S. and internationally, addressing the needs of a global clientele. Additionally, he has expanded his knowledge to include trademark prosecution and litigation.

Career & Education

|
    • University of Michigan Law School, J.D., Certificate of Merit (highest grade)
      Early American Legal History, 2024
    • DePaul University, B.S., magna cum laude, Physics, 2021
    • University of Michigan Law School, J.D., Certificate of Merit (highest grade)
      Early American Legal History, 2024
    • DePaul University, B.S., magna cum laude, Physics, 2021
    • Illinois
    • U.S. Court of Appeals for the Federal Circuit
    • U.S. Court of Appeals for the Seventh Circuit
    • Illinois
    • U.S. Court of Appeals for the Federal Circuit
    • U.S. Court of Appeals for the Seventh Circuit

Dawson's Insights

Client Alert | 4 min read | 03.27.25

Proposed Bills Limit Pharmaceutical Patents: Panacea for Patients or Poison for Pharmaceutical Producers?

Senators John Cornyn(R-Texas), Chuck Grassley (R-Iowa), Richard Blumenthal (D-Conn.), and Dick Durbin (D.-Ill.) recently sponsored two bills, introduced on March 14th, that would affect patents in the pharmaceutical industry....

Dawson's Insights

Client Alert | 4 min read | 03.27.25

Proposed Bills Limit Pharmaceutical Patents: Panacea for Patients or Poison for Pharmaceutical Producers?

Senators John Cornyn(R-Texas), Chuck Grassley (R-Iowa), Richard Blumenthal (D-Conn.), and Dick Durbin (D.-Ill.) recently sponsored two bills, introduced on March 14th, that would affect patents in the pharmaceutical industry....